Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets 
Japan Business Sentiment Hits Four-Year High, Boosting Expectations of BOJ Rate Hike 
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
South Korea Extends Bond Market Stabilization Measures Amid Rising Financial Risks 
3M, an American conglomerate operating in industry, worker safety, healthcare, and consumer goods, announced the appointment of Bryan Hanson as chief executive officer of its new healthcare business.
On Tuesday, Aug. 22, it said that the newly-appointed executive will lead the healthcare group that it plans to spinoff. Last year, 3M shared its plans to create a new branch for its healthcare line.
There are plans to turn this health business into a listed company where 3M will keep its 19.9% stake. The firm is looking to complete the spinoff before this year ends. As per Reuters, the plan is to direct the focus of this healthcare unit to oral care, wound care, and healthcare technology, accounting for around 25% of the company's $34.43 billion in sales in 2022.
In any case, Hanson will officially join 3M on Sept. 1 and immediately assume the role of CEO of the firm's Health Care Business Group. Before this appointment, he worked as president and chief at Zimmer Biomet since 2017. He was promoted to the chairman post in 2021, and now he has left the Indiana-based medical equipment manufacturer to move to 3M.
Aside from hiring a new CEO, 3M also revealed that Carrie Cox, the former chairman and CEO of Humacyte Inc., will also be the chairman of the board of directors for the healthcare spinoff.
"We are pleased to have Bryan join us to successfully complete the spinoff of our Health Care business and build a leading independent medical technology innovation company," 3 M's chairman and chief executive officer, Mike Roman, said in a press release. "His industry expertise, ability to drive growth, and track record of building a strong culture and teams will make an immediate impact."
Photo by: visuals/Unsplash
